Actual practice of standard treatment for pulmonary nontuberculous mycobacteriosis in Japan

• Published in: Respiratory medicine Vol. 158; pp. 67 - 69
• Main Authors: Morimoto, Kozo, Izumi, Kiyohiko, Ato, Manabu, Hasegawa, Naoki, Mitarai, Satoshi
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.10.2019; Elsevier Limited
• Subjects: Antibiotics; Clarithromycin resistant; Disease; Drug therapy; Guideline; Insurance claim; Lung diseases; Mortality; Mycobacteriosis; Patients; R&D; Research & development; Treatment; United States > US; Japan; Guideline; Clarithromycin resistant; Treatment; Insurance claim

The details of the practice of treating nontuberculous mycobacterial pulmonary disease (NTMPD) have not been studied in Japan. We studied a random sample of 2% (184) of the 9,200 patients with incident NTM-PD in 2010 who received standard three-drug therapy for at least some of their treatment betwe...